药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfacytine
Dextromoramide
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Dextromoramide.
Sulfacytine
Etorphine
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Etorphine.
Sulfacytine
Ethylmorphine
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Ethylmorphine.
Sulfacytine
Bezitramide
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Bezitramide.
Sulfacytine
Diamorphine
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Diamorphine.
Sulfacytine
Dihydroetorphine
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Dihydroetorphine.
Sulfacytine
Methadyl acetate
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Methadyl acetate.
Sulfacytine
Deoxyepinephrine
The risk or severity of Cardiac Arrhythmia can be increased when Deoxyepinephrine is combined with Canagliflozin.
Sulfacytine
Theodrenaline
The risk or severity of Cardiac Arrhythmia can be increased when Theodrenaline is combined with Canagliflozin.
Sulfacytine
Racepinephrine
The risk or severity of Cardiac Arrhythmia can be increased when Racepinephrine is combined with Canagliflozin.
Sulfacytine
Protokylol
The risk or severity of Cardiac Arrhythmia can be increased when Protokylol is combined with Canagliflozin.
Sulfacytine
Levonordefrin
The risk or severity of Cardiac Arrhythmia can be increased when Levonordefrin is combined with Canagliflozin.
Sulfacytine
Tetrandrine
The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Canagliflozin.
Sulfacytine
Lomerizine
The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Canagliflozin.
Sulfacytine
Emopamil
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Canagliflozin.
Sulfacytine
Dexverapamil
The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Canagliflozin.
Sulfacytine
Gallopamil
The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Canagliflozin.
Sulfacytine
Xylometazoline
The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Canagliflozin.
Sulfacytine
Fish oil
The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Fish oil.
Sulfacytine
WIN 55212-2
The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with WIN 55212-2.